In vitro experiments using a dual-luciferase reporter assay confirmed that SOX4 binds to MAPK1 and promotes its transcription, establishing the role of the SOX4/MAPK1/IQGAP1 regulatory axis in pancreatic cancer cells (60). Here, SOX4 is linked to pancreatic neoplasm.